Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on April 16th, 2026.
Xolair dosing depends on body weight and serum IgE levels, with amounts ranging from 75 mg to 600 mg every 2 to 4 weeks, depending on the condition.
Different conditions require different dosing schedules, and a healthcare provider must determine the right amount.
The medication carries a boxed warning for anaphylaxis, but can be administered either in a healthcare setting or at home for eligible patients after provider training.
Missed doses should be given as soon as possible, with the schedule adjusted accordingly.
Doctronic offers free AI doctor visits to help patients understand their medications and dosing questions.
Xolair (omalizumab) is an injectable medication used to treat several conditions, including asthma, chronic hives, nasal polyps, and food allergies. Getting the right dose is essential for the medication to work properly. The dosing process is not simple because it depends on multiple factors unique to each patient. Xolair dosage for asthma in adults and children 6 years and older ranges from 75 mg to 600 mg via subcutaneous injection every 2 or 4 weeks. These amounts are determined by measuring serum total IgE levels and body weight before starting treatment. A healthcare provider will run blood tests and take measurements to calculate the correct dose for each patient.
Form |
Strength |
Typical Adult Dose |
Typical Children's Dose |
Frequency |
Route |
Maximum Dose per Administration |
|---|---|---|---|---|---|---|
Prefilled Syringe |
75 mg/0.5 mL |
75-600 mg |
75-600 mg (6+ years) |
Every 2-4 weeks |
Subcutaneous |
600 mg |
Prefilled Syringe |
150 mg/mL |
150-600 mg |
150-600 mg (6+ years) |
Every 2-4 weeks |
Subcutaneous |
600 mg |
Vial |
150 mg |
150-600 mg |
150-600 mg (6+ years) |
Every 2-4 weeks |
Subcutaneous |
600 mg |
For asthma patients, dosing is based on pre-treatment serum IgE levels and body weight. Patients receive between 75 mg and 600 mg every 2 to 4 weeks. The goal is to reduce the number of asthma attacks and decrease the need for other medications. Children as young as 6 years old can receive Xolair for asthma using the same dosing calculations as adults.
Chronic hives require a different approach. The standard dose is 150 mg or 300 mg every 4 weeks. Unlike asthma dosing, the amount does not depend on IgE levels or body weight. Most patients start at 150 mg, and the dose may increase to 300 mg if symptoms do not improve.
Patients with nasal polyps typically receive 75 mg to 600 mg every 2 to 4 weeks. The dosing follows the same IgE and weight-based calculations used for asthma. This treatment helps reduce polyp size and improve breathing.
For food allergies, dosing also depends on IgE levels and body weight. Treatment aims to reduce the risk of severe food allergies, such as peanut, milk, and egg allergies. Patients must still avoid their trigger foods, but Xolair provides an extra layer of protection.
Adults with asthma or nasal polyps receive doses ranging from 75 mg to 600 mg based on their IgE levels and weight. For chronic hives, adults typically receive 150 mg or 300 mg regardless of these factors. The injection is given under the skin, usually in the arm or thigh. Doctronic can help adults understand their specific dosing requirements through free AI consultations.
Children 6 years and older can receive Xolair for asthma using the same IgE and weight-based dosing as adults. For chronic hives, children 12 years and older receive 150 mg or 300 mg every 4 weeks. Children as young as 1 year old may now receive Xolair for IgE-mediated food allergies, based on updated FDA approval in 2024, with doses calculated based on their individual measurements.
Missing a dose happens sometimes. Patients should contact their healthcare provider right away to reschedule. The missed dose should be given as soon as possible. After that, the regular schedule can resume based on the makeup dose date. Waiting too long between doses may reduce how well the medication works.
Significant weight changes may require dose adjustments. If a patient gains or loses a large amount of weight, the healthcare provider will recalculate the dose. This ensures the medication remains effective. Regular check-ins help track these changes.
IgE levels can change over time. Providers typically measure IgE before starting treatment and use that baseline for dosing. Retesting may be performed if the treatment does not appear to be working. Dose adjustments based on new IgE measurements require careful medical supervision.
The FDA requires a boxed warning for anaphylaxis on Xolair packaging. This severe allergic reaction can occur after the first dose or even after more than a year of treatment. Administration should initially occur under medical supervision, but eligible patients may continue therapy at home after provider approval and training. Patients should remain under observation for at least 30 minutes after each injection, as directed by their healthcare provider. Signs of anaphylaxis include difficulty breathing, swelling, rapid heartbeat, and dizziness.
Overdose is rare because the medication is given by healthcare professionals or under guided home use. If too much is given, patients should seek immediate medical attention. No specific antidote exists, so treatment focuses on managing symptoms.
Patients should always receive injections in a medical setting with proper emergency equipment available or use at home only if approved and trained by their provider. Keeping all scheduled appointments ensures consistent treatment. Reporting any unusual symptoms after injection helps catch problems early. Carrying identification that lists Xolair as a current medication can help in emergencies.
Patients should inform all healthcare providers about their Xolair treatment. This includes dentists, specialists, and emergency room staff. Keeping a record of injection dates and doses helps track treatment progress.
Most patients notice improvement within 12 to 16 weeks of starting treatment. Some conditions may show results sooner. Consistent dosing is important for the medication to reach its full effect.
After the first few doses in a medical setting, some patients may be eligible for home administration with prefilled syringes. A healthcare provider must approve home use and provide proper training.
Many insurance plans cover Xolair for approved conditions. Annual costs can range from approximately $30,000 to $60,000 depending on dosage and frequency. Patient assistance programs may help reduce out-of-pocket costs.
Some patients may need dose adjustments if the medication becomes less effective. A healthcare provider can evaluate whether increasing the dose or changing the treatment schedule might help.
No specific foods interact with Xolair. Patients should inform their provider about all current medications, including over-the-counter drugs and supplements, before starting treatment.
Xolair dosing requires careful calculation based on individual patient factors. Working closely with a healthcare provider ensures safe and effective treatment. For questions about Xolair or other medications, Doctronic. offers free AI doctor visits that provide personalized information. The platform also offers affordable telehealth video visits with licensed doctors available around the clock in all 50 states.
Understanding Xolair Uses and DosagesXolair (omalizumab) is an injectable medication used to treat several conditions, including asthma, chronic hives, nasal polyps, and food [...]
Read More
Join 50,000+ readers using Doctronic to understand symptoms, medications,
and next steps.
Add your phone number below to get health updates and exclusive VIP offers.
By providing your phone number, you agree to receive SMS updates from Company. Message and data rates may apply. Reply “STOP” to opt-out anytime. Read our Privacy Policy and Terms of Service for more details.
Save your consults. Talk with licensed doctors and manage your health history.
